News Coverage for Bio-Solutions Corp. (OTCQB: BISU) - August 27, 2013

Stock News

  • Last Trade: $0.0179
  • Change: 0.00
  • Open: $0.0174
  • High: $0.0179
  • Low: $0.0174
  • Volume: 27644

Company Snapshot
Bio-Solutions Corp.

1250 NE Loop 410
Suite:200
San Antonio, TX 78209

www.biosolutionscorp.com

Directors:
William Gallagher CEO, CFO
Tel: 210-378-8104
Email: info@biosolutionscorp.com


Ticker Symbol: BISU
Exchange: OTCQB
Shares Outstanding: 156,943,593
Float: APX 15,000,000 +/-

52 Week Low: $0.0065
52 Week High: $0.032

 



Investors Links
BISU Message Boards
Investors Hub



BISU Mobi Site
Never miss news alerts from
BISU -

Text PRESS to 545454 for
Free News Alerts
 

 

Bio-Solutions Corp. Announces National Direct Response Marketing Campaign for Type2Defense™
 

GVP Digital Media, a top direct response marketing company to employ unique strategy to launch innovative consumer product
 

SAN ANTONIO, August 28, 2013 /PRNewswire via COMTEX/ Bio-Solutions Corp. (OTCQB: BISU) today announces a major step in their company’s expansion process across the USA and commitment to growth across America; as management celebrates the national roll-out of a Direct Response Infomercial and Marketing Campaign for it’s flagship product Type2Defense™.

Get News Alerts & Stock Updates for Bio-Solutions  delivered directly to your Mobile Phone. Text PRESS to 545454 (News alerts are free; however standard message & data rates may apply. Check with your carrier for more details.)

BISU AlertsType2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product’s goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

Bill Gallagher, CEO of Bio-Solutions Corp said, “We are very excited to be launching our unique product via direct response television in the USA, and especially feeling confident that partnering with GVP Digital Media will give us the edge for a successful campaign."

Compared to other consumer groups, diabetics are 1.6 times more likely to use alternative medicine either exclusively or as a complement to traditional treatment. GVP Digital Media, a leader in Direct Response, will begin to actively market Type2Defense through their media contacts and network of brokers, sales consultants and agents. GVP has already started test marketing Type2Defense in a National radio campaign.

“We are extremely excited to be partnering with Type2Defense™,” said Harry Oates, President of Direct Response Marketing for GVP Digital Media. “We believe that they offer a truly innovative and incredible product that today’s consumers will soon be discovering through the direct response marketing endeavour we’re engaging in.” Bio-Solutions has already opened the retail marketplace on Amazon, and now television, radio and magazine advertising will support product sales and drive consumers to purchase the products, also through social media and their website.

Gallagher added “We will also be offering additional products as line extensions after the initial product launch. These may be at various flavors that will widen existing sales. “ The demand for natural products that effectively control glucose continues to rise. Even in times of general economic distress, consumers increase their consumption of natural health products. Effective organic products likeType2 Defense can improve everyday wellbeing and save money on future medical costs by maintaining health.

About Bio-Solutions Corp.

Bio-Solutions Corp. markets new and very effective organic products; our lead product is Type2 Defense™. Type2Defense™ a Diabetic Supplement Drink. Type2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product’s goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants. Consumers can find more information about the company and its products by going to http://www.BioSolutionsCorp.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business
strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.

SOURCE Bio-Solutions Corp 

About Bio-Solutions Corp. (OTCQB: BISU)


Bio-Solutions Corp, Owns and Markets Type2 Defense(TM) (the “Product” or the “Supplement”) is a glucose control dietary supplement powder formulated to support healthy glucose levels in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to support healthy glucose levels for type 2 diabetics and pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.

Bio-Solutions Corp intends to sell and market the Product on the Internet. The target market is type 2 and pre-diabetics. The Product is delivered in 10 gram plastic packets (i.e. Emergent- C) conveniently packaged in a box of 30 servings. The targeted market is health conscious individuals that have been diagnosed as Type II diabetics or individuals who are concerned with pre-diabetic symptoms.

The company and Management believe that there is a growing Diabetic TARGET market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2 Defense is a powder blend of natural ingredients that has been developed to maintain healthy blood glucose levels. The
BISU Alerts Type2 Defense powder blend is a flavorful supplement when mixed with water becomes an effective vehicle that encourages its target market with a convenient and all natural pure health beverage containing green tea blended with cinnamon and blueberry flavoring along with Type2 Defense proprietary blend. The Product’s goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

Protect your body naturally.

The Company is pleased to announce a new era for Bio-Solutions Corp. (OTCBB:BISU). The company markets new and very effective
organic products; our lead product is Type2 Defense™. Type2Defense™ a Diabetic Supplement Drink.

“This company recognizes the diabetic epidemic that is happening in this country and throughout the world. We are excited to offer such a dynamic nutritional supplement that supports healthy living in the diabetic community”, says EVP Bill Gallagher. The company’s focus is now on type 2 and pre-diabetic products. The targeted market for Type2 Defense™ is heath conscious individuals that have been diagnosed as Type II diabetics or individuals who are concerned with pre-diabetic symptoms.

Bio-Solutions Corp. acquired Type2 Defense™ brand in September of 2012, including all formulas, copyrights, trademarks, records and research. The Company has launched the new product to tap into the rapidly growing demand for diabetic and functional supplementation.Type2 Defense™ will soon be sold on the company’s website www.type2defense.com (currently under development).

 

 

Recent Bio-Solutions Corp. (OTCQB: BISU) 


Bio-Solutions Corporation Announces Campaign on Lockerdome.com to Help Raise Money for the Benefit of Juvenile Diabetes

SAN ANTONIO, August 27, 2013 /PRNewswire via COMTEX/ -- Bio-Solutions Corporation (OTCQB: BISU) is pleased to announce that we have initiated a campaign on Lockerdome.com to help raise money for the benefit of Juvenile Diabetes. Lockerdome.com is the premier destination on the internet for both professional and amateur athletes. Monthly traffic to Lockerdome.com is in excess of 14 million visitors per month and Bio-Solutions is confident that it can reach athletes who have diabetes through Lockerdome.com and help them reach their training potential by using the company's product, Type 2 Defense.


The Bio-Solutions Corp. page on Lockerdome.com will allow young athletes with diabetes to interact with pro athletes with diabetes. This one on one interaction with the pros will show young diabetics that diabetes is not an obstacle to achieving greatness. The pro ranks are full of star athletes who have made it to the top without letting diabetes get in their way. We invite everyone who is interested to check out the page for news on product endorsers and product giveaways.

Every order that originates from the Lockerdome.com campaign, will result in a portion of net proceeds being donated to Juvenile Diabetes. Both Bio-Solutions Corp and Lockerdome.com support the activities of Juvenile Diabetes on a regional and national basis. We encourage everyone to visit the new Bio-Solutions Corp page on Lockerdome.com by clicking biosolutionscorp.lockerdome.com.

 

Bio-Solutions Corporation Launches www.Type2Defense.com to Take Online Orders

SAN ANTONIO, TEXAS, Jul 09, 2013 (Marketwired via COMTEX) -- Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) www.BioSolutionsCorp.com - In a joint effort to accommodate the growing demand for the company's product, Bio-Solutions Corp. has launched its official online retail store at www.Type2Defense.com while maintaining its distribution agreement with the Amazon store Healthy Provisions.  Consumers will now have two options when ordering the product; through www.Type2Defense.com or Healthy Provisions on Amazon. This will enable Bio-Solutions Corp. to broaden its consumer base and reach out to clients on a global scale where changing lifestyles and health awareness among consumers is expected to drive the health supplements market in the years to come. Type2 Defense(TM) will cater to type2 diabetes patients, which are 90-95% of all diabetics.

"The market of diabetes supplements is witnessing a steady growth in the last decade mainly due to the growing awareness among consumers of the effect of consuming health supplements. Some of the major factors driving the global supplements market include the growing global ageing population and the growing concern among consumer to stay healthy and fit. Huge opportunities lie in the diabetes supplement industry, where growth is driven mainly due to the demand from knowledgeable consumers looking for a healthy alternative. Our company is strategically positioned to benefit from this," said Bill Gallagher, president and CEO at Bio-Solutions Corp.

Bio-Solutions Corp. has hired Josh Williams, an independent consultant to brand Type2Defense(TM) thru mainstream media via multiple channels - including high-profile, profession athlete endorsements.

 

 

Type2Defense(TM) Available on the Amazon Healthy Provisions Online Store

SAN ANTONIO, TEXAS, Jul 08, 2013 (Marketwired via COMTEX) -- Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) BISU Alerts(www.BioSolutionsCorp.com) has done it! In this first step to the company's expansion process across the USA and commitment to growth across America, management celebrates the national roll-out of its flagship product Type2Defense(TM) on the Healthy Provisions Amazon store via its partnership agreement with Kee Holdings Inc. The product can be purchased by following the online ordering link on the company website at: www.biosolutionscorp.com.  Kee Holdings Inc. is a leading procurer of health, nutrition and wellness products leading the way to many of the internet giants online today. Since 2006, Kee Holdings has grown to represent over 7,500 well-known consumer products and offers both wholesale and drop ship fulfillment strategies to clients such as Amazon.com and Overstock.com. Kee Holdings will be managing all product orders and shipping for Bio-Solution Corp's on-line sales.

Type2Defense(TM) is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

"We are very excited to be bringing Type2Defense(TM) to the consumer on the Healthy Provisions Amazon store and we highly appreciate the support that Amazon and its partners offer to manufacturers and suppliers. We believe that there is a growing market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2Defense(TM) is aimed at filling in that gap and our company is confident that it will benefit from the $15 billion dollar U.S diabetes market," said Bill Gallagher, president and CEO at Bio-Solutions Corporation.

Consumers can find more information about the product by going to http://www.biosolutionscorp.com/products/..

 

Bio-Solutions Corporation Completes Initial Production of Diabetic Product, Type2 Defense

SAN ANTONIO, TEXAS, Jun 27, 2013 (Marketwired via COMTEX) -- Bio-Solutions Corporation (OTCBB: BISU)(PINKSHEETS: BISU) is pleased to announce that the company has completed its initial order of the diabetic product Type2 Defense with Nutricap Labs located in Farmingdale, New York. The successful completion of the initial production order is an important milestone for Bio-Solutions Corporation. The company is now positioned to distribute final product samples to the different groups that are presently considering endorsing the Type2 Defense product and begin set-up of proper distribution channels for the product.

Type2 Defense is a preventative supplement for people who are diabetic or who are pre-diabetic. The product helps regulate blood sugar and blood pressure levels in diabetic and pre-diabetic subjects, especially for those who are insulin-resistant. "The company recognizes the diabetic epidemic that is happening in this country and throughout the world. We are excited to now be able to offer such a dynamic nutritional supplement that supports healthy living in the diabetic community" says CEO Bill Gallagherr

 

FN Media Disclaimer


FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) is a third party publishing provider which disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For services performed FNMG has been compensated three thousand nine fifty hundred dollars for coverage on this BISU news release by a non-affiliated third party. FNMG HOLDS NO SHARES OF Bio-Solutions (OTCQB: BISU)

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.